Arkolith/Insider Trading/STOK/Form 4

Kaye Edward M. MD

DirectorStoke Therapeutics, Inc. (STOK) · full profile →Form 4 · filed Aug 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$403K
Net Open-Market Flow
-$403K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2026Sell(S)12K$32.01$382K125K
Aug 18, 2026Sell(S)637$32.47$21K125K
Aug 14, 2026Option exercise(M)26K—$0137K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 14, 2026Option exercise(M)26K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001522780-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Stoke Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp